Publications by authors named "Jeffrey Miceli"

Claim this Profile
A
A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil.
Terence Fullerton, Brendon Binneman, William David, Marielle Delnomdedieu, James Kupiec, Jeffrey Miceli

Alzheimers Res Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
Diego Garcia-Borreguero, Jeffrey Patrick, Sarah DuBrava, Philip M Becker, Alan Lankford, Jeffrey Miceli

Sleep· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pregabalin with pramipexole for restless legs syndrome.
Richard P Allen, Crystal Chen, Diego Garcia-Borreguero, Olli Polo, Sarah DuBrava, Jeffrey Miceli

N Engl J Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.
Karl Rickels, Thomas M Shiovitz, Tanya S Ramey, Jerry J Weaver, Lloyd E Knapp, Jeffrey J Miceli

Int Clin Psychopharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
A John Camm, Onur N Karayal, Herbert Meltzer, Sheela Kolluri, Cedric O'Gorman, Jeffrey Miceli

CNS Drugs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of food on the absorption of oral ziprasidone.
Jeffrey J Miceli, Paul Glue, Jeffrey Alderman, Keith Wilner

Psychopharmacol Bull· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome.
Richard Allen, Crystal Chen, Adina Soaita, Christopher Wohlberg, Lloyd Knapp, Jeffrey Miceli

Sleep Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
Jeffrey J Miceli, Thomas G Tensfeldt, Thomas Shiovitz, Richard J Anziano, Cedric O'Gorman

Clin Ther· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
Jeffrey J Miceli, Thomas G Tensfeldt, Thomas Shiovitz, Richard Anziano, Cedric O'Gorman

Pharmacotherapy· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.
Melissa P DelBello, Mark Versavel, Kathleen Ice, David Keller, Jeffrey Miceli

J Child Adolesc Psychopharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiographic changes with ziprasidone.
Antony Loebel, Jeffrey Miceli, Phillip Chappell, Cynthia Siu

J Am Acad Child Adolesc Psychiatry· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents.
Floyd R Sallee, Jeffrey J Miceli, Thomas Tensfeldt, Lisa Robarge, Keith Wilner

J Am Acad Child Adolesc Psychiatry· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.
Jeffrey J Miceli, Keith D Wilner, Suzanne K Swan, Thomas G Tensfeldt

J Clin Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
Edmund P Harrigan, Jeffrey J Miceli, Richard Anziano, Eric Watsky, Karen R Reeves

J Clin Psychopharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission.
Floyd R Sallee, Donald L Gilbert, Alexander A Vinks, Jeffrey J Miceli, Lisa Robarge

J Am Acad Child Adolesc Psychiatry· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziprasidone metabolism, aldehyde oxidase, and clinical implications.
Christine Beedham, Jeffrey J Miceli, R Scott Obach

J Clin Psychopharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery.
Keith D Wilner, Richard J Anziano, Arlene C Johnson, Jeffrey J Miceli, James R Fricke

J Clin Psychopharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis